ClinicalTrials.gov
ClinicalTrials.gov Menu

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01221870
Recruitment Status : Unknown
Verified July 2012 by Genta Incorporated.
Recruitment status was:  Recruiting
First Posted : October 15, 2010
Last Update Posted : July 24, 2012
Sponsor:
Information provided by (Responsible Party):
Genta Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2012
  Estimated Study Completion Date : January 2013